Cleared Traditional

K212890 - Nyquist.IQ

K212890 is an FDA 510(k) clearance for Nyquist.IQ, manufactured by Omega Medical Imaging, LLC. The device is a Class 2 Radiology device with product code JAA cleared through the Traditional 510(k) pathway after a 94-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2021
Decision
94d
Days
Class 2
Risk

K212890 is an FDA 510(k) clearance for the Nyquist.IQ. Classified as System, X-ray, Fluoroscopic, Image-intensified (product code JAA), Class II - Special Controls.

Submitted by Omega Medical Imaging, LLC (Sanford, US). The FDA issued a Cleared decision on December 13, 2021 after a review of 94 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Omega Medical Imaging, LLC devices

FDA 510(k) Submission Details - K212890

510(k) Number K212890 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 2021
Decision Date December 13, 2021
Days to Decision 94 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d faster than avg
Panel avg: 107d · This submission: 94d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAA Device Classification - Class 2, Special Controls

Product Code JAA System, X-ray, Fluoroscopic, Image-intensified
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAA System, X-ray, Fluoroscopic, Image-intensified

All 146
Devices cleared under the same product code (JAA) and FDA review panel - the closest regulatory comparables to K212890.
CombiDiagnost R90
K232910 · Philips Medical Systems Dmc GmbH · Oct 2023
XIDF-AWS801, Angio Workstation (Alphenix Workstation), V9.5
K232526 · Canon Medical Systems Corporation · Sep 2023
Nautilus
K220871 · Dornier Medtech America, Inc. · Apr 2022
ProxiDiagnost N90
K212837 · Philips Medical Systems Dmc GmbH · Sep 2021
DR 800 with DSA, DR 800
K212145 · Agfa N.V. · Aug 2021
Insight Agile DRF
K210469 · Imaging Engineering, LLC · Jul 2021